Neuromodulation and Cognitive Training for Substance Use Disorders

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT04426214
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • tDCS — DEVICE
    We will apply tDCS in combination with cognitive training. All participants receive cognitive training, and will be randomized to receive either active or sham tDCS
  • Cognitive Training — BEHAVIORAL
    cognitive training on computer

Study Details

The relapsing nature of substance use disorder is a major obstacle to successful treatment. About 70% of those entering treatment will relapse within one year. To improve treatment outcome, new interventions targeting the underlying brain biomarkers of relapse vulnerability hold significant promise in reducing this critical public health problem. This study is testing a new intervention, namely tDCS-Augmented Cognitive Training, to engage these brain biomarkers to improve cognition and improve treatment outcomes.

Key Dates

Start date
Jul 16, 2021
Status verified
Aug 2025
Primary completion
Sep 1, 2026
Completion
Sep 1, 2026

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Active tDCS
  • Placebo Comparator: Sham tDCS

Primary Outcome Measure

Percent of participants with clean drug screens [ Time Frame: 2 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Minnesota FairviewMinneapolisMinnesota55454
Melanie Stimac
[email protected]
612-301-2449

Find similar trials in Minneapolis, MN

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
University of Minnesota Fairview· Minneapolis, MN

Related Studies